• Adjuvance is a privately held biopharmaceutical company dedicated to empowering health through fundamental breakthroughs in vaccine adjuvant design and manufacturing. Adjuvants are critical components that are added to many vaccines to improve the immune response.


    Our culture of creativity and innovation is grounded in our advanced technologies, our team, and our intellectual property. Our collaborative R&D effort drives focused application of resources to highest priority opportunities for both new product introductions and technology development.

  • Management Team

    :”

  • Board of Directors

  • Advisory Board

  • Our Founders

    DavidYGin

    Adjuvance was originally founded by a group of scientists, including Phil Livingston, Govind Ragupathi, Jeffrey Gardner and which was led by the late esteemed chemist David Gin. Dr. Gin was a Member and Tri-Institutional Professor in the Molecular Pharmacology and Chemistry Program at the Memorial Sloan-Kettering Cancer Center. Dr. Gin was working at the nexus of synthetic chemistry, clinical trials, and research to develop new, safer, and more-potent immunological and therapeutic agents for cancer and infectious diseases. His research program focused on the chemical synthesis of complex carbohydrate conjugates and bioactive alkaloids. The synthesis of novel adjuvants for cancer and infectious disease vaccines were a major effort in Dr. Gin’s research, an effort Adjuvance carries on today. His major innovations in this area form the core of Adjuvance Technologies’ intellectual property. Dr. Gin obtained his BSc in Chemistry at the University of British Columbia in 1989, received his PhD in synthetic organic chemistry at the California Institute of Technology in 1994, and held a two-year NSERC postdoctoral appointment at Harvard. He began his independent academic career in 1996 at the Chemistry Department at the University of Illinois at Urbana-Champaign, where he remained for 10 years before moving his laboratory to MSKCC in 2006. The Sloan Kettering Institute currently hosts an annual David Gin Syposium Lecture and the American Chemical Society offers the David Y. Gin Young Investigator Award in Dr. Gin’s memory.